hotspot -WSS

hotspot

author：explore 2025-10-01 23:07:06 - browse：62

Stain of a biopsy specimen of a rhabdoid tumor -- health coverage from STAT — Stain of a biopsy specimen of a rhabdoid tumor. Wikimedia Commons

Most targeted cancer drugs work like tranquilizer darts, snaring an overzealous gene that has spurred the cell into murderously rapid growth.

But many tumors don’t have a hyperactive gene. Like the mayhem in “Cat in the Hat,” they are enabled by parental absence. They grow because the genes that are meant to provide discipline, guiding the activity of other genes or self-destructing a cell whose DNA is too damaged, are broken or missing.

These tumors have bedeviled researchers for decades. Restoring or fixing a protein is far harder than breaking it. And that’s bad news for humanity: Cancer is far more likely to be caused by such “tumor-suppressor” genes than by one gene run amok.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： NIH nominee Bertagnolli will get October confirmation hearing

Wikipedia

WSS

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

NIH nominee Bertagnolli will get October confirmation hearing

Humana sues Biden admin over Medicare Advantage audit rule

AstraZeneca chief proposes a novel edit to the drug pricing bill

House transparency, PBM reform bill gains bipartisan support

Readout Newsletter: What happened with Sarepta's Duchenne data

focus

hotspot

Wikipedia

Medicare proposal to cover medical devices draws a mixed reaction

Readout Newsletter: What happened with Sarepta's Duchenne data

Apple is now the first public company to be valued at $3 trillion

Cassava reveals details — and problems — with Alzheimer's study

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

NIH nominee Bertagnolli will get October confirmation hearing

Activists slam private health insurers over coverage restrictions

Testing for cancer recurrence creates a new limbo for patients

Duchenne breakthrough therapy leaves behind pioneering families

Traditional Chinese medicine benefits explored in new JAMA study

leisure time

First Opinion Podcast: How to protect health care in times of war

NIH nominee Bertagnolli will get October confirmation hearing

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Chimpanzees, like humans and whales, get menopause: Study

FDA has safety concerns on CRISPR

Trump surgeon general acknowledges mistakes during Covid

hotspot

entertainment

Wikipedia

entertainment